Search results
CNBC Daily Open: Apple upgrades Siri with AI
CNBC· 7 days agoThe S&P 500 and the Nasdaq Composite inched to record highs ahead of the Federal Reserve's interest rate decision. Shares of Apple fell 1.9% after the iPhone maker delivered its long-awaited ...
National Academies Issue New Broad Definition of Long COVID
Medscape· 6 days agoA new broadly inclusive definition of long COVID from the National Academies of Sciences,...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 2 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration (FDA) announced ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 2 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Factbox-Layoffs pile up in US, Canada as companies uncertain of economy
Investing.com· 4 days ago* Amazon (NASDAQ: AMZN )'s job cuts include less than 5% of employees at Buy with Prime unit, 5% at...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 7 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced Monday that in phase 3 clinical trials ...
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's...
Benzinga· 7 days agoShares of Skye Bioscience, Inc. SKYE fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and ...
The 'Impressive' Results That Sent This Top 1% Player To A Record
Investor's Business Daily· 5 days agoThe company is working on a treatment called del-brax for patients with facioscapulohumeral muscular...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
Layoffs pile up in U.S., Canada as companies uncertain of economy | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 5 days agoCompanies in the U.S. and Canada have continued their job cuts in 2024 after letting go thousands...